1. The Nuclear Receptor Nr4a1 Acts as a Microglia Rheostat and Serves as a Therapeutic Target in Autoimmune-Driven Central Nervous System Inflammation.
- Author
-
Rothe T, Ipseiz N, Faas M, Lang S, Perez-Branguli F, Metzger D, Ichinose H, Winner B, Schett G, and Krönke G
- Subjects
- Adenosine Triphosphate pharmacology, Animals, Cells, Cultured, Central Nervous System Diseases therapy, Cytokines biosynthesis, Cytokines immunology, Encephalomyelitis, Autoimmune, Experimental immunology, Encephalomyelitis, Autoimmune, Experimental physiopathology, Encephalomyelitis, Autoimmune, Experimental prevention & control, Gene Expression Regulation, Humans, Inflammation, Macrophage Activation, Mice, Mice, Inbred C57BL, Microglia drug effects, Microglia immunology, Multiple Sclerosis therapy, Neurodegenerative Diseases therapy, Nitric Oxide biosynthesis, Nitric Oxide metabolism, Nuclear Receptor Subfamily 4, Group A, Member 1 deficiency, Central Nervous System immunology, Microglia physiology, Nuclear Receptor Subfamily 4, Group A, Member 1 genetics, Nuclear Receptor Subfamily 4, Group A, Member 1 metabolism
- Abstract
Microglia cells fulfill key homeostatic functions and essentially contribute to host defense within the CNS. Altered activation of microglia, in turn, has been implicated in neuroinflammatory and neurodegenerative diseases. In this study, we identify the nuclear receptor (NR) Nr4a1 as key rheostat controlling the activation threshold and polarization of microglia. In steady-state microglia, ubiquitous neuronal-derived stress signals such as ATP induced expression of this NR, which contributed to the maintenance of a resting and noninflammatory microglia phenotype. Global and microglia-specific deletion of Nr4a1 triggered the spontaneous and overwhelming activation of microglia and resulted in increased cytokine and NO production as well as in an accelerated and exacerbated form of experimental autoimmune encephalomyelitis. Ligand-induced activation of Nr4a1 accordingly ameliorated the course of this disease. Our current data thus identify Nr4a1 as regulator of microglia activation and potentially new target for the treatment of inflammatory CNS diseases such as multiple sclerosis., (Copyright © 2017 by The American Association of Immunologists, Inc.)
- Published
- 2017
- Full Text
- View/download PDF